Refractory/resistant cytomegalovirus infection in transplant recipients: An update Review


Authors: Royston, L.; Papanicolaou, G. A.; Neofytos, D.
Review Title: Refractory/resistant cytomegalovirus infection in transplant recipients: An update
Abstract: Despite the significant progress made, CMV infection is one of the most frequent infectious complications in transplant recipients. CMV infections that become refractory or resistant (R/R) to the available antiviral drugs constitute a clinical challenge and are associated with increased morbidity and mortality. Novel anti-CMV therapies have been recently developed and introduced in clinical practice, which may improve the treatment of these infections. In this review, we summarize the treatment options for R/R CMV infections in adult hematopoietic cell transplant and solid organ transplant recipients, with a special focus on newly available antiviral agents with anti-CMV activity, including maribavir and letermovir. © 2024 by the authors.
Keywords: adult; review; hematopoietic stem cell transplantation; drug effect; drug resistance; physiology; virology; antivirus agent; drug administration; drug therapy; quinazolines; cytomegalovirus infection; quinazoline derivative; cytomegalovirus; graft recipient; intravenous drug administration; pharmacology; antiviral resistance; drug resistance, viral; oral drug administration; antiviral agents; infectious complication; acetic acid derivative; drug interaction; etiology; adverse event; complication; organ transplantation; benzimidavir; transplant recipients; cytomegalovirus infections; acetates; humans; human; dichlororibofuranosylbenzimidazole; letermovir; 5,6 dichlorobenzimidazole riboside; cytomegalovirus (cmv); maribavir; refractory infection; resistant infection
Journal Title: Viruses
Volume: 16
Issue: 7
ISSN: 1999-4915
Publisher: MDPI  
Date Published: 2024-07-01
Start Page: 1085
Language: English
DOI: 10.3390/v16071085
PUBMED: 39066247
PROVIDER: scopus
PMCID: PMC11281367
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors